Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2011/09/001995
CTRI/2011/09/001995
Recruiting
Phase 2

Effect of Semenax on semen characteristics with Protocol ID: DM/100710/SMX/MSD

eading Edge Marketing0 sites96 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Low Semen Volume

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: null- Low Semen Volume
Sponsor
eading Edge Marketing
Enrollment
96
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
eading Edge Marketing

Eligibility Criteria

Inclusion Criteria

  • •Men with hypospermia (semen volume lower than 2ml) or normospermia (semen volume 2\-5\.5ml) on at least two semen analyses)
  • •Men with normozoospermia (sperm concentration 20x106 /ml
  • •Men with mild oligospermia (sperm concentration10\-19\.99x106/ml or moderate oligospermia (sperm concentration 4\-10x106/ml)
  • •Men with normal to subnormal levels of sperm motility and sperm morphology
  • •Men willing to maintain a consistent abstinence period of 2 to 7 days each time before producing semen samples and comply with other semen collection procedures

Exclusion Criteria

  • •1\.Aspermia (no semen)
  • •2\.Absence of Fructose /low fructose (13 µmol per ejaculate)
  • •3\.ph7\.2 or 8\.0
  • •4\.Presence of red blood cells (hemospermia)
  • •5\.Excessive leucocytes or leucospermia (peroxidase positive cells1x106 /ml)
  • •6\.Severe impairment of ejaculate volume or sperm concentration or sperm motility or sperm morphology
  • •7\.Ejaculate volume5\.5 ml (Includes hyperspermia i.e 7 ml of ejaculate volume)
  • •8\.Moderate impairment occurring in more than two sperm parameters: sperm concentration, sperm morphology and sperm motility
  • •9\.Neurological disorders such as multiple sclerosis, , demyelization disease, tumors, degenerative conditions etc
  • •10\.Presence of diabetic neuropathy or complications, use of insulin for glycemic control, duration of diabetes over five years from detection

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Effect of seminal exosome on the quality of frozen spermOligoasthenoteratozoospermia.
IRCT20230207057345N1Tehran University of Medical Sciences100
Not yet recruiting
Not Applicable
Semen parameters in patients with cancer
CTRI/2020/09/027720Gunasheela Surgical and Maternity Hospital
Recruiting
Phase 1
Proteomics-based study of seminal plasma in patients with different hypoconstitution and spermatosis
ITMCTR2000003474The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
Completed
Not Applicable
Effects of sperm selection by zona pellucida binding method on fertility outcomes and embryo morphokinitics
IRCT20200705048021N1Yazd University of Medical Sciences70
Active, not recruiting
Phase 1
Effects of Spermidine intake on the immune response to Covid-19 vaccineFor assessing the immune cell function after COVID-19 vaccine, peripheral blood mononuclear cells (PBMC) will be separated after blood sampling and measurements as follows will be done:• FACS analysis• DNA and RNA analysis of immune related molecules.• Assays of T-cell function, B-cell function and macrophage/monocyte functionTherapeutic area: Body processes [G] - Immune system processes [G12]
EUCTR2021-001391-42-ATMedical University of Graz40